NASDAQ:APDN Applied DNA Sciences (APDN) Stock Price, News & Analysis → Exposed: 10 CENT Crypto to Explode April 20th? (From True Market Insiders) (Ad) Free APDN Stock Alerts $0.24 -0.05 (-17.31%) (As of 04/24/2024 ET) Add Compare Share Share Today's Range$0.22▼$0.2850-Day Range$0.29▼$0.6852-Week Range$0.22▼$1.86Volume1.20 million shsAverage Volume130,978 shsMarket Capitalization$4.05 millionP/E RatioN/ADividend YieldN/APrice Target$1.50 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Get Applied DNA Sciences alerts: Email Address Applied DNA Sciences MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside528.1% Upside$1.50 Price TargetShort InterestHealthy1.59% of Shares Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment-0.67Based on 2 Articles This WeekInsider TradingN/AProj. Earnings GrowthGrowingFrom ($0.63) to ($0.48) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.2.09 out of 5 stars 3.5 Analyst's Opinion Consensus RatingApplied DNA Sciences has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Amount of Analyst CoverageApplied DNA Sciences has only been the subject of 1 research reports in the past 90 days. Previous Next 3.0 Short Interest Percentage of Shares Shorted1.59% of the outstanding shares of Applied DNA Sciences have been sold short.Short Interest Ratio / Days to CoverApplied DNA Sciences has a short interest ratio ("days to cover") of 2.4, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Applied DNA Sciences has recently increased by 3.68%, indicating that investor sentiment is decreasing. Previous Next 0.0 Dividend Strength Dividend YieldApplied DNA Sciences does not currently pay a dividend.Dividend GrowthApplied DNA Sciences does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for APDN. Previous Next 1.3 News and Social Media Coverage News SentimentApplied DNA Sciences has a news sentiment score of -0.67. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.51 average news sentiment score of Industrial Products companies.News Coverage This WeekMarketBeat has tracked 2 news articles for Applied DNA Sciences this week, compared to 1 article on an average week.Search InterestOnly 2 people have searched for APDN on MarketBeat in the last 30 days. This is a decrease of -60% compared to the previous 30 days.MarketBeat Follows7 people have added Applied DNA Sciences to their MarketBeat watchlist in the last 30 days. This is an increase of 40% compared to the previous 30 days. Previous Next 0.8 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Applied DNA Sciences insiders have not sold or bought any company stock.Percentage Held by Insiders10.25% of the stock of Applied DNA Sciences is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 22.22% of the stock of Applied DNA Sciences is held by institutions. Previous Next 1.3 Earnings and Valuation Earnings GrowthEarnings for Applied DNA Sciences are expected to grow in the coming year, from ($0.63) to ($0.48) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Applied DNA Sciences is -0.44, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Applied DNA Sciences is -0.44, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioApplied DNA Sciences has a P/B Ratio of 0.66. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad True Market InsidersExposed: 10 CENT Crypto to Explode April 20th?Former Wall Street Insider and Professional Money Manager Reveals 4 Cryptos BETTER Than BitcoinClick For My #1 FREE Crypto for 2024 About Applied DNA Sciences Stock (NASDAQ:APDN)Applied DNA Sciences, Inc., a biotechnology company, develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA) in the Americas, Europe, Asia, and internationally. It operates through three segments: Therapeutic DNA Production Services; MDx Testing Services; and DNA Tagging and Security Products and Services. The Therapeutic DNA Production Services segment develops and commercializes the LinearDNA platform, which enables a cell-free manufacture of high-fidelity synthetic DNA sequences for use in nucleic acid-based therapeutics. The MDx Testing Services segment provides clinical molecular diagnostics (MDx) testing and clinical laboratory testing services; COVID-19 testing services, including test scheduling, sample collection, and automated results reporting for higher education institutions, private clients, and businesses under the safeCircle trademark; polymerase chain reaction (PCR) for production and detection of DNA and RNA; and MDx test kits and related supplies, as well as Isotopic analysis testing services. The DNA Tagging and Security Products and Services segment offers SigNature Molecular Tags, which provides a methodology to authenticate goods within large and complex supply chains for materials, such as cotton, nutraceuticals, and other products; SigNify portable DNA readers and SigNify consumable reagent test kits; and fiberTyping, which uses PCR-based DNA detection to detect a product's naturally occurring DNA sequences for the purposes of product provenance authentication and supply chain security. The company was formerly known as Datalink Systems, Inc. and changed its name to Applied DNA Sciences, Inc. in 2002. Applied DNA Sciences, Inc. was founded in 1983 and is headquartered in Stony Brook, New York.Read More APDN Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart APDN Stock News HeadlinesApril 9, 2024 | marketbeat.comThe Top 5 Analysts Ranked by Marketbeat and Stocks They CoverMarketbeat's many investor tools include analysts' rankings and sentiment trackers. These tools help investors and traders gauge market sentiment, showing trends and changes, updated revisions, and new reports.April 9, 2024 | marketbeat.comThe Top 5 Analysts Ranked by Marketbeat and Stocks They Cover (APDN)Analysts rate the stocks, but who rates the analysts? This is a look at five of the highest-rated analysts tracked by Marketbeat.com based on 12-month ROI.April 24, 2024 | True Market Insiders (Ad)Exposed: 10 CENT Crypto to Explode April 20th?Former Wall Street Insider and Professional Money Manager Reveals 4 Cryptos BETTER Than BitcoinApril 21, 2024 | americanbankingnews.comApplied DNA Sciences (NASDAQ:APDN) Now Covered by Analysts at StockNews.comMarch 14, 2024 | finanznachrichten.deApplied DNA Sciences, Inc.: Applied DNA to Showcase Linea DNA and Linea IVT Platforms at 24th Annual World Vaccine CongressMarch 12, 2024 | msn.comApplied DNA Sciences files to sell 11.29M shares of common stock for holdersFebruary 24, 2024 | msn.comApplied DNA Sciences (APDN) Price Target Increased by 12.50% to 2.30February 23, 2024 | benzinga.comApplied DNA Sciences Stock (NASDAQ:APDN) Earnings Dates and Earning CallsApril 24, 2024 | True Market Insiders (Ad)Exposed: 10 CENT Crypto to Explode April 20th?Former Wall Street Insider and Professional Money Manager Reveals 4 Cryptos BETTER Than BitcoinFebruary 22, 2024 | wsj.comApplied DNA Sciences Inc.February 22, 2024 | benzinga.comApplied DNA Sciences Stock (NASDAQ:APDN) Dividends: History, Yield and DatesFebruary 10, 2024 | finance.yahoo.comApplied DNA Sciences First Quarter 2024 Earnings: Beats ExpectationsFebruary 10, 2024 | insidermonkey.comApplied DNA Sciences, Inc. (NASDAQ:APDN) Q1 2024 Earnings Call TranscriptFebruary 9, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Applied DNA Sciences (APDN) and Viking Therapeutics (VKTX)February 9, 2024 | finance.yahoo.comQ1 2024 Applied DNA Sciences Inc Earnings CallFebruary 8, 2024 | finanznachrichten.deApplied DNA Sciences, Inc.: Applied DNA Announces First Quarter Fiscal Year 2024 Financial ResultsFebruary 8, 2024 | benzinga.comRecap: Applied DNA Sciences Q1 EarningsFebruary 8, 2024 | markets.businessinsider.comApplied DNA Announces First Quarter Fiscal Year 2024 Financial ResultsFebruary 8, 2024 | finance.yahoo.comApplied DNA Announces First Quarter Fiscal Year 2024 Financial ResultsFebruary 7, 2024 | benzinga.comEarnings Preview For Applied DNA SciencesFebruary 5, 2024 | finance.yahoo.comApplied DNA to Report First Quarter Fiscal 2024 Financial Results on Thursday, February 8, 2024February 3, 2024 | investing.comApplied DNA Sciences Inc (APDN)February 2, 2024 | finanznachrichten.deApplied DNA Sciences, Inc.: Applied DNA Announces Closing of $3.44 Million Registered Direct Offering Priced At-the-Market Under Nasdaq RulesFebruary 2, 2024 | finance.yahoo.comApplied DNA Announces Closing of $3.44 Million Registered Direct Offering Priced At-the-Market Under Nasdaq RulesJanuary 31, 2024 | finanznachrichten.deApplied DNA Sciences, Inc.: Applied DNA Announces $3.44 Million Registered Direct Offering Priced At-the-Market Under Nasdaq RulesJanuary 31, 2024 | msn.comApplied DNA announces $3.44M registered direct offeringJanuary 31, 2024 | finance.yahoo.comApplied DNA Announces $3.44 Million Registered Direct Offering Priced At-the-Market Under Nasdaq RulesSee More Headlines Receive APDN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Applied DNA Sciences and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings2/08/2024Today4/24/2024Next Earnings (Estimated)5/09/2024Fiscal Year End9/30/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorIndustrial Products Industry Testing laboratories Sub-IndustryN/A Current SymbolNASDAQ:APDN CUSIPN/A CIK744452 Webwww.adnas.com Phone(631) 240-8800Fax631-240-8900Employees52Year FoundedN/APrice Target and Rating Average Stock Price Target$1.50 High Stock Price Target$1.50 Low Stock Price Target$1.50 Potential Upside/Downside+481.4%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)($0.54) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-9,950,000.00 Net Margins-80.14% Pretax Margin-81.25% Return on Equity-159.93% Return on Assets-71.49% Debt Debt-to-Equity RatioN/A Current Ratio1.77 Quick Ratio1.63 Sales & Book Value Annual Sales$13.37 million Price / Sales0.33 Cash FlowN/A Price / Cash FlowN/A Book Value$0.36 per share Price / Book0.72Miscellaneous Outstanding Shares16,980,000Free Float15,239,000Market Cap$4.38 million OptionableOptionable Beta0.07 10 Best Stocks to Own in 2024Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio. Get This Free Report Key ExecutivesDr. James A. Hayward Ph.D. (Age 70)Sc.D., Chairman, President & CEO Comp: $468kMs. Beth M. Jantzen CPA (Age 48)Chief Financial Officer Comp: $300kMs. Judith Murrah (Age 66)COO, Chief Information Officer & Secretary Comp: $325kMr. Clay Shorrock Esq. (Age 39)J.D., Chief Legal Officer & Executive Director of Business Development Comp: $300kMr. Sanjay M. HurryExecutive Director of Investor Relations & Corporate CommunicationsMr. Tony BensonManaging Director of EMEAMr. Joseph L. MagnoSales ConsultantMr. Warren PearlsonSales ConsultantMore ExecutivesKey CompetitorsMobilicomNASDAQ:MOBJE CleantechNASDAQ:JCSEDigital AllyNASDAQ:DGLYCrown ElectroKineticsNASDAQ:CRKNAmerican RebelNASDAQ:AREBView All CompetitorsInstitutional OwnershipAMH Equity LtdSold 217,232 shares on 2/2/2024Ownership: 2.693%View All Institutional Transactions APDN Stock Analysis - Frequently Asked Questions Should I buy or sell Applied DNA Sciences stock right now? 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Applied DNA Sciences in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" APDN shares. View APDN analyst ratings or view top-rated stocks. What is Applied DNA Sciences' stock price target for 2024? 1 analysts have issued twelve-month price objectives for Applied DNA Sciences' stock. Their APDN share price targets range from $1.50 to $1.50. On average, they anticipate the company's share price to reach $1.50 in the next year. This suggests a possible upside of 528.1% from the stock's current price. View analysts price targets for APDN or view top-rated stocks among Wall Street analysts. How have APDN shares performed in 2024? Applied DNA Sciences' stock was trading at $0.6168 on January 1st, 2024. Since then, APDN shares have decreased by 61.3% and is now trading at $0.2388. View the best growth stocks for 2024 here. When is Applied DNA Sciences' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, May 9th 2024. View our APDN earnings forecast. How were Applied DNA Sciences' earnings last quarter? Applied DNA Sciences, Inc. (NASDAQ:APDN) announced its earnings results on Thursday, February, 8th. The technology company reported ($0.09) earnings per share for the quarter, topping analysts' consensus estimates of ($0.31) by $0.22. The technology company earned $0.89 million during the quarter, compared to analyst estimates of $0.70 million. Applied DNA Sciences had a negative trailing twelve-month return on equity of 159.93% and a negative net margin of 80.14%. When did Applied DNA Sciences' stock split? Applied DNA Sciences shares reverse split on Thursday, April 25th 2024. The 1-20 reverse split was announced on Thursday, April 25th 2024. The number of shares owned by shareholders will be adjusted after the closing bell on Thursday, April 25th 2024. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split. What is James A. Hayward's approval rating as Applied DNA Sciences' CEO? 2 employees have rated Applied DNA Sciences Chief Executive Officer James A. Hayward on Glassdoor.com. James A. Hayward has an approval rating of 100% among the company's employees. This puts James A. Hayward in the top 10% of approval ratings compared to other CEOs of publicly-traded companies. 100.0% of employees surveyed would recommend working at Applied DNA Sciences to a friend. What other stocks do shareholders of Applied DNA Sciences own? Based on aggregate information from My MarketBeat watchlists, some companies that other Applied DNA Sciences investors own include Inovio Pharmaceuticals (INO), Advanced Micro Devices (AMD), Ekso Bionics (EKSO), Micron Technology (MU), Arbutus Biopharma (ABUS), VBI Vaccines (VBIV), Gilead Sciences (GILD), Vaxart (VXRT), Sorrento Therapeutics (SRNE) and Intel (INTC). How do I buy shares of Applied DNA Sciences? Shares of APDN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:APDN) was last updated on 4/24/2024 by MarketBeat.com Staff From Our Partnerstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersThe #1 Crypto for 2024InvestorPlaceDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsA.I. is a Tidal Wave - Here’s What to BuyChaikin Analytics Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Applied DNA Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
